Пошук по сайту
Авторизація
Логин:
Пароль:
Регистрация
Забыли свой пароль?
Періодика
Медична інформатика та інженерія
Партнери
Поиск информации по диагнозу / Med And Me Издательский дом ЗАСЛАВСКИЙ Zepter
Технічна підтримка

Американські ринки не судинних стентів (U.S. Markets for Nonvascular Stents)




Nonvascular stenting has been used for decades in the palliation of transient and chronic obstructions of natural circulatory pathways that enable the transfer of air, bodily fluids, and other substances involved in systemic metabolic and energy exchange. These circulatory pathways include the biliary tree as well as the gastrointestinal (GI), pulmonary, and urinary tracts. In 2010, nonvascular stenting systems were used in approximately 516,500 endoluminal recanalization procedures in the U.S., generating an estimated $168.8 million in related sales. Over the forecast period covered by this report, the number of nonvascular stenting procedures in the U.S. is expected to increase at a compound annual rate of 1.5%; during the same period, corresponding dollar sales are expected to increase at a compound annual rate of 2.8%, reaching approximately $189.2 million in the year 2014.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. nonvascular stents market. Major topics covered by this report include a discussion of current and emerging nonvascular stenting technologies; a clinical overview of nonvascular conditions targeted by stenting (e.g., biliary GI, pulmonary, and urinary tract obstruction) and an analysis of the procedure volumes and market forecasts for biliary, GI, pulmonary, and urologic stenting systems in the U.S.

TABLE OF CONTENTS

EXECUTIVE SUMMARY


a. Nonvascular Stenting Systems
b. Stent Design and Materials
c. Products and Procedures

i. Biliary Stenting
ii. Gastrointestinal Stenting
iii. Pulmonary Stenting
iv. Urologic Stenting
v. Combined Procedure Volumes Forecast

d. Market Analysis

i. Biliary Stents
ii. Gastrointestinal Stents
iii. Pulmonary Stents
iv. Urologic Stents
v. Combined Market Analysis

Exhibit ES-1: 2010, Estimated Incidence of Nonvascular Conditions Targeted by Stenting Technologies
Exhibit ES-2: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit ES-3: Nonvascular Stenting Systems, Market Forecast, 2009-2014

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

1.1 Stent Design
1.1.1 Vascular Stents
1.1.2 Nonvascular Stents
1.1.3 Stent Deployment Mechanisms
1.2 Stent Materials
1.2.1 Metal Stents
1.2.1.1 Absorbable Magnesium Alloys
1.2.1.2 Cobalt Alloys
1.2.1.3 Nickel-Titanium Alloys
1.2.1.4 Stainless Steel
1.2.2 Standard Polymeric Stents
1.2.3 Biodegradable Polymeric Stents
1.3 Stent Coatings
1.3.1 Radiopacity Enhancement
1.3.2 Biocompatibility Enhancement
1.3.3 Active Therapeutic Enhancement
1.3.3.1 Drug-Eluting Stents
1.3.3.1.1 Antirestenotic Drug-Eluting Stents
1.3.3.1.2 Drug Delivery Techniques
1.3.4 Stent Coverings and Linings
Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements
Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs
Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials
Exhibit 1-4: Selected Polymeric Stent Materials
Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents
Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents

2. CLINICAL OVERVIEW OF NONVASCULAR STENTS

2.1 Nonvascular Conditions Targeted by Stenting
2.1.1 Biliary Tract Obstruction
2.1.1.1 Clinical Indications
2.1.1.2 Implantation Techniques
2.1.1.3 Biliary Stent Types
2.1.1.3.1 Plastic Devices
2.1.1.3.2 Metal Devices
2.1.1.4 Procedure Volumes
2.1.2 Gastrointestinal Tract Obstruction
2.1.2.1 Colorectal Stenting
2.1.2.1.1 Clinical Indications
2.1.2.1.2 Technology
2.1.2.1.3 Implantation Techniques
2.1.2.2 Esophageal Stenting
2.1.2.2.1 Technology
2.1.2.2.2 Implantation Techniques
2.1.2.3 Procedure Volumes
2.1.3 Pulmonary Tract Obstruction
2.1.3.1 Clinical Indications
2.1.3.2 Types of Pulmonary Stenting Systems
2.1.3.3 Procedure Volumes
2.1.4 Urinary Tract Obstruction
2.1.4.1 Ureteral Obstruction
2.1.4.1.1 Urinary Stone Disease
2.1.4.1.2 Ureteral Strictures
2.1.4.1.3 Ureteral Stenting
2.1.4.2 Urethral Obstruction
2.1.4.2.1 Benign Prostatic Hyperplasia
2.1.4.2.2 Urethral Strictures
2.1.4.2.3 Urethral Stenting
2.1.4.3 Procedure Volumes
Exhibit 2-1: 2010, Biliary Obstruction, Facts and Figures
Exhibit 2-2: Biliary Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit 2-3: 2010, Colorectal Obstruction, Facts and Figures
Exhibit 2-4: 2010, Esophageal Obstruction, Facts and Figures
Exhibit 2-5: Gastrointestinal Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit 2-6: 2010, Pulmonary Tract Obstruction, Facts and Figures
Exhibit 2-7: Pulmonary Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit 2-8: 2010, Upper Urinary Tract Obstruction, Facts and Figures
Exhibit 2-9: 2010, Lower Urinary Tract Obstruction, Facts and Figures
Exhibit 2-10: Urologic Stenting, Procedure Volumes Forecast, 2009-2014

3. NONVASCULAR STENTS MARKET

3.2.1 Biliary Stenting Systems
3.2.1.1 Products
3.2.1.2 Market Forecast
3.2.1.3 Competitive Analysis
3.2.2 Gastrointestinal Stenting Systems
3.2.2.1 Products
3.2.2.2 Market Forecast
3.2.2.3 Competitive Analysis
3.2.3 Pulmonary Stenting Systems
3.2.3.1 Products
3.2.3.2 Market Forecast
3.2.3.3 Competitive Analysis
3.2.4 Urologic Stenting Systems
3.2.4.1 Ureteral Stenting Products
3.2.4.2 Urethral Stenting Products
3.2.4.3 Market Forecast
3.2.4.4 Competitive Analysis
Exhibit 3-1: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit 3-2: Nonvascular Stents, Market Forecast, 2009-2014
Exhibit 3-3: 2011, Selected Metal and Plastic Biliary Stents
Exhibit 3-4: Biliary Stents, Market Forecast, 2009-2014
Exhibit 3-5: 2010, Biliary Stents Market, Share by Supplier
Exhibit 3-6: 2011, Selected Colorectal Stents
Exhibit 3-7: 2011, Selected Esophageal Stents
Exhibit 3-8: Metal Gastrointestinal Stents, Market Forecast, 2009-2014
Exhibit 3-9: 2010, Colorectal Stents Market, Share by Supplier
Exhibit 3-10: 2010, Metal Esophageal Stents Market, Share by Supplier
Exhibit 3-11: 2011, Selected Pulmonary Stents
Exhibit 3-12: Pulmonary Stents, Market Forecast, 2009-2014
Exhibit 3-13: 2010, Pulmonary Stents Market, Share by Supplier
Exhibit 3-14: 2011, Selected Ureteral Stents
Exhibit 3-15: 2011, Selected Prostatic Stents
Exhibit 3-16: Urologic Stents, Market Forecast, 2009-2014
Exhibit 3-17: 2010, Ureteral Stents Market, Share by Supplier
Exhibit 3-18: 2010, Urethral Stents Market, Share by Supplier

4. COMPANY PROFILES

4.1 AbbeyMoor Medical, Inc.
4.2 American Medical Systems, Inc.
4.3 Boston Scientific Corporation
4.4 Bryan Corporation
4.5 Cook Group, Inc.
4.6 Cordis Corporation/Johnson & Johnson
4.7 Gyrus ACMI/Olympus Corporation
4.8 Hood Laboratories, Inc.
4.9 Merit Endotek/Merit Medical Systems, Inc.
Publisher: Medtech Insight
Перекладач: translate.google.com
Новини
03.03.2023  Науково доведено: через смартфони ви можете старіти швидше
24.02.2023  Стимуляція спинного мозку відновлює постінсультну функцію рук
17.02.2023  Вчені відкрили здатність жирної їжі руйнувати мозок
10.02.2023  В Індії розробили неінвазивний тест, який використовує штучний інтелект для виявлення раку молочної залози
01.02.2023  Як спостереження за світанками та заходами сонця впливає на здоров'я – вчені
25.01.2023  Аналіз крові для ранньої діагностики хвороби Альцгеймера розробили вчені
18.01.2023  Людина з серцем свині. Пацієнту вперше пересадили серце тварини
11.01.2023  Вчені пояснили, чому оливкову олію варто пити ложками
21.11.2022  Вчені виявили ще одну причину високого ризику атеросклерозу
18.11.2022  Імплантована помпа доставила протиракові ліки у пухлини мозку
16.11.2022  Шум вночі може бути причиною безсоння та серцево-судинних захворювань
14.11.2022  ЩО ТРЕБА ЗНАТИ ПРО ЦУКРОВИЙ ДІАБЕТ: ТИПИ, СИМПТОМИ, УСКЛАДНЕННЯ
11.11.2022  Виявилося, в епідемії ожиріння винен лише один тип їжі
09.11.2022  Проказа: давня хвороба, здатна регенерувати органи
07.11.2022  "Чарівні гриби" можуть лікувати важку депресію
04.11.2022  Нове випробування пропонує переваги CV з EPA: RESPECT-EPA
02.11.2022  Майже 500 українських медиків завершили навчання з тактичної медицини
01.11.2022  Чи можна людям з діабетом пити алкоголь
31.10.2022  Знайдено овоч, здатний знизити цукор у крові відразу на 20%
28.10.2022  Людська печінка може працювати 100 років
HINARI
PubMed